ARTICLE SUMMARY:
A neuromodulation device inserted in the pulmonary artery has the potential to increase heart contractility without the negative effects of inotropic drugs.
For more than one million patients hospitalized with acute decompensated heart failure (ADHF) the prognosis is bleak. Only one in three patients hospitalized with heart failure survives for five years or more.
